characteristics.text: SAMN11078094
characteristics.characteristic: External Id
characteristics.text: Moffitt Cancer Center
characteristics.characteristic: INSDC center name
characteristics.text: 2022-10-20T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-10-20T01:27:21.013Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS4458793
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS4458793
characteristics.characteristic: SRA accession
characteristics.text: 92.1
characteristics.characteristic: cell line
characteristics.text: Uveal melanoma cells
characteristics.ontologyTerms: http://www.ebi.ac.uk/efo/EFO_1000244
characteristics.characteristic: cell type
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Uveal melanoma cells
characteristics.ontologyTerms: http://www.ebi.ac.uk/efo/EFO_1000244
characteristics.characteristic: source_name
characteristics.text: 03_Trametinib_rep1
characteristics.characteristic: title
characteristics.text: cells treated with trametinib (MEKi) (10nM, 24 hr)
characteristics.characteristic: treatment